| Year |
Citation |
Score |
| 2014 |
Desphande A, Xia G, Boerma LJ, Vines KK, Atigadda VR, Lobo-Ruppert S, Grubbs CJ, Moeinpour FL, Smith CD, Christov K, Brouillette WJ, Muccio DD. Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. Bioorganic & Medicinal Chemistry. 22: 178-85. PMID 24359708 DOI: 10.1016/J.Bmc.2013.11.039 |
0.323 |
|
| 2014 |
Boerma LJ, Xia G, Qui C, Cox BD, Chalmers MJ, Smith CD, Lobo-Ruppert S, Griffin PR, Muccio DD, Renfrow MB. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain. The Journal of Biological Chemistry. 289: 814-26. PMID 24187139 DOI: 10.1074/Jbc.M113.476861 |
0.317 |
|
| 2009 |
Liu Z, Teng L, Bailey SK, Frost AR, Bland KI, LoBuglio AF, Ruppert JM, Lobo-Ruppert SM. Epithelial transformation by KLF4 requires Notch1 but not canonical Notch1 signaling. Cancer Biology & Therapy. 8: 1840-51. PMID 19717984 DOI: 10.4161/Cbt.8.19.9440 |
0.405 |
|
| 2009 |
Jiang W, Deng W, Bailey SK, Nail CD, Frost AR, Brouillette WJ, Muccio DD, Grubbs CJ, Ruppert JM, Lobo-Ruppert SM. Prevention of KLF4-mediated tumor initiation and malignant transformation by UAB30 rexinoid. Cancer Biology & Therapy. 8: 289-98. PMID 19197145 DOI: 10.4161/cbt.8.3.7486 |
0.342 |
|
| 2007 |
Li X, Deng W, Lobo-Ruppert SM, Ruppert JM. Gli1 acts through Snail and E-cadherin to promote nuclear signaling by β-catenin Oncogene. 26: 4489-4498. PMID 17297467 DOI: 10.1038/Sj.Onc.1210241 |
0.322 |
|
| 2006 |
Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, Frost AR. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biology & Therapy. 5: 674-83. PMID 16855373 DOI: 10.4161/Cbt.5.6.2906 |
0.382 |
|
| 2006 |
Li X, Deng W, Nail CD, Bailey SK, Kraus MH, Ruppert JM, Lobo-Ruppert SM. Snail induction is an early response to Gli1 that determines the efficiency of epithelial transformation Oncogene. 25: 609-621. PMID 16158046 DOI: 10.1038/Sj.Onc.1209077 |
0.432 |
|
| 2005 |
Huang CC, Liu Z, Li X, Bailey SK, Nail CD, Foster KW, Frost AR, Ruppert JM, Lobo-Ruppert SM. KLF4 and PCNA identify stages of tumor initiation in a conditional model of cutaneous squamous epithelial neoplasia. Cancer Biology & Therapy. 4: 1401-8. PMID 16357510 DOI: 10.4161/Cbt.4.12.2355 |
0.385 |
|
| 2005 |
Foster KW, Liu Z, Nail CD, Li X, Fitzgerald TJ, Bailey SK, Frost AR, Louro ID, Townes TM, Paterson AJ, Kudlow JE, Lobo-Ruppert SM, Ruppert JM. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 24: 1491-500. PMID 15674344 DOI: 10.1038/Sj.Onc.1208307 |
0.347 |
|
| 2004 |
Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M, Chhieng DC, Grizzle WE, Engler JA, Krontiras H, Bland KI, LoBuglio AF, Lobo-Ruppert SM, Ruppert JM. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 2709-19. PMID 15102675 DOI: 10.1158/1078-0432.Ccr-03-0484 |
0.33 |
|
| 2001 |
Zhou D, Lobo-Ruppert SM. Transcription of the Schizosaccharomyces pombe U2 gene in vivo and in vitro is directed by two essential promoter elements. Nucleic Acids Research. 29: 2003-11. PMID 11353068 DOI: 10.1093/Nar/29.10.2003 |
0.425 |
|
| 2000 |
McCulloch V, Hardin P, Peng W, Ruppert JM, Lobo-Ruppert SM. Alternatively spliced hBRF variants function at different RNA polymerase III promoters. The Embo Journal. 19: 4134-43. PMID 10921893 DOI: 10.1093/Emboj/19.15.4134 |
0.439 |
|
| Show low-probability matches. |